Overweight and obesity influence contraceptive choice
Dr Annabel Forsythe and Valerie Warner Findlay explore the latest recommendations from the FSRH about contraceptive use in women who are overweight or obese
FSRH recommends tailoring CHC regimens to widen contraceptive choice
Dr Katie Boog explores updated guidance from the Faculty of Sexual & Reproductive Healthcare on combined hormonal contraception, including how to assess suitability and discuss risks, benefits, and tailored regimens
Breast pain: what’s the diagnosis?
Dr Toni Hazell uses case studies to explore three possible causes of breast pain (mastalgia) and how each condition should be managed in primary care
Heavy menstrual bleeding: new treatments offer more options
Dr Rachel Brown explores updated NICE recommendations for the diagnosis and treatment of heavy menstrual bleeding
Pregnancy: take opportunities to promote planning and prevention
Dr Sue Mann explains why pregnancy planning is important and how preconception care can improve maternal and child health outcomes
Test and reflect
Related Guidelines summaries
-
NICE LARC guideline
This guideline covers important points to raise with women that may benefit from long-acting reversible contraception
-
NICE recommendations for women with pelvic organ prolapse
Summary includes recommendations on non-surgical management of prolapse, and assessment and management of complications associated with mesh surgery.
-
Urinary incontinence and pelvic organ prolapse in women: management
Summary of NICE guidance covers history taking, assessing urinary incontinence, investigations, non-surgical management, and indicators for referral.
-
SIGN FASD guideline
Failure to recognise prenatal alcohol exposure (PAE) as a possible cause of behavioural difficulties, such as ADHD, may contribute to adverse outcomes for the child. This summary covers the identification of children affected by prenatal alcohol exposure and includes a succinct and helpful diagnostic algorithm.
-
Uncomplicated recurrent UTI guideline
This guideline was developed by a multidisciplinary expert panel: Rees J et al with the support of a grant from a pharmaceutical company.